Viewing Study NCT00002895

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:12 PM
Ignite Modification Date: 2026-01-03 @ 3:15 AM
Study NCT ID: NCT00002895
Status: COMPLETED
Last Update Posted: 2013-12-04
First Post: 1999-11-01
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Early Chemotherapy Based on CA 125 Level Alone Compared With Delayed Chemotherapy in Treating Patients With Recurrent Ovarian Epithelial , Fallopian Tube, or Primary Peritoneal Cancer
Sponsor: Medical Research Council
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Fallopian Tube Cancer View
None Ovarian Cancer View
None Primary Peritoneal Cavity Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent ovarian epithelial cancer View
None primary peritoneal cavity cancer View
None fallopian tube cancer View